This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This VWA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 44-72 amino acids from the N-terminal region of human VWA2.
vWA2
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
Biotin
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
VWA2 (vWA2)
(Von Willebrand Factor A Domain Containing 2 (vWA2))
vwa2 antikoerper, amaco antikoerper, AMACO antikoerper, CCSP-2 antikoerper, NET42 antikoerper, Amaco antikoerper, von Willebrand factor A domain containing 2 antikoerper, von Willebrand factor A domain containing 2 S homeolog antikoerper, VWA2 antikoerper, vwa2.S antikoerper, vwa2 antikoerper, Vwa2 antikoerper
Hintergrund
VWA2, also named as AMACO and CCSP2, is a novel candidate serological marker of colon neoplasia. VWA2 is found in the media of variesy of established cell lines of both fibroblast and epithelial origin.